Zobrazeno 1 - 10
of 27
pro vyhledávání: '"GianLudovico Rapaccini"'
Autor:
Alessandro, Vitale, Gianluca, Svegliati-Baroni, Alessio, Ortolani, Monica, Cucco, Giulio V, Dalla Riva, Edoardo G, Giannini, Fabio, Piscaglia, Gianludovico, Rapaccini, Mariella, Di Marco, Eugenio, Caturelli, Marco, Zoli, Rodolfo, Sacco, Giuseppe, Cabibbo, Fabio, Marra, Andrea, Mega, Filomena, Morisco, Antonio, Gasbarrini, Francesco Giuseppe, Foschi, Gabriele, Missale, Alberto, Masotto, Gerardo, Nardone, Giovanni, Raimondo, Francesco, Azzaroli, Gianpaolo, Vidili, Filippo, Oliveri, Filippo, Pelizzaro, Rafael, Ramirez Morales, Umberto, Cillo, Franco, Trevisani, Luca, Miele, Giulio, Marchesini, Fabio, Farinati, Alessandro, Di Bucchianico
BackgroundMetabolic dysfunction-associated fatty liver disease (MAFLD) represents a new inclusive definition of the whole spectrum of liver diseases associated to metabolic disorders. The main objective of this study was to compare patients with MAFL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e0b7fb7418a4eb5bca934de4b41108e
https://hdl.handle.net/11588/902316
https://hdl.handle.net/11588/902316
Autor:
F. Pizzolante, Gianludovico Rapaccini, Nicoletta De Matthaeis, Maria Assunta Zocco, Maria Elena Ainora, Antonio Gasbarrini, Luca Miele, Antonio Grieco, A. Liguori, Laura Riccardi
Publikováno v:
Minerva gastroenterology. 67(2)
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and its prevalence is even higher in patients with risk factors such as type 2 diabetes and obesity. Liver biopsy is the gold standard for diagnosis
Autor:
Valerio Papa, Lorenzo Maria Vetrone, Antonio Tursi, Francesco Franceschi, Loris Riccardo Lopetuso, Antonio Gasbarrini, Alfredo Papa, Marcello Covino, Gianludovico Rapaccini, Benedetta Simeoni
Publikováno v:
Journal of Personalized Medicine
Volume 11
Issue 2
Journal of Personalized Medicine, Vol 11, Iss 80, p 80 (2021)
Volume 11
Issue 2
Journal of Personalized Medicine, Vol 11, Iss 80, p 80 (2021)
The prevalence of acute diverticulitis (AD) has progressively increased in recent decades, with correspondingly greater morbidity and mortality. The aim of the study is to develop a predictive score to identify patients with the highest risk of compl
Autor:
Antonio Liguori, Fabrizio Pizzolante, Luca Miele, Maria Assunta Zocco, Gianludovico Rapaccini, M.E. Ainora, Antonio Gasbarrini, Nicoletta De Matthaeis, Antonio Grieco
Publikováno v:
Metabolism: clinical and experimental. 112
Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease and represent a common finding in highly prevalent metabolic disorders (i.e. type 2 diabetes, metabolic syndrome, obesity). Non-alcoholic steatohepatitis (NASH) requ
Autor:
Alfredo Papa, Laura Maria Minordi, Matteo Neri, Antonio Gasbarrini, Alessandra Di Veronica, Gianludovico Rapaccini, Valerio Papa, Loris Riccardo Lopetuso
Enterocutaneous fistulas (ECFs) is a manifestation of penetrating Crohn's disease (CD) that is challenging to treat and has considerable morbidity and mortality rates.This review aims to explore the practical and updated principles for the optimal tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daff2d8edfd614a9f0a961d77190c449
http://hdl.handle.net/10807/179121
http://hdl.handle.net/10807/179121
Autor:
Antonio Gasbarrini, Gianludovico Rapaccini, Silvio Danese, Valerio Papa, Alfredo Papa, Antonio Tursi
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 2115, p 2115 (2020)
Journal of Clinical Medicine
Journal of Clinical Medicine
Patients with inflammatory bowel disease (IBD) have an increased risk of venous thromboembolism (VTE). Alongside the traditional acquired and genetic risk factors for VTE, patients with IBD have pathogenic and clinical peculiarities that are responsi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c667a1e88899239e0d9dfca080401d22
http://hdl.handle.net/10807/179758
http://hdl.handle.net/10807/179758
Autor:
Consuelo Cefalo, Stefania Boccia, Antonio Gasbarrini, Antonio Liguori, Dario Arzani, Roberta Pastorino, Giuseppe Marrone, Luca Miele, Gianludovico Rapaccini, Antonio Grieco, Maria Adele Alberelli, Marco Biolato, Salvatore Petta, Valentina Giorgio, Antonio Craxì
Background and aim Increased intestinal permeability plays a key role in the pathogenesis of fat deposition in the liver. The aim of our study was to assess whether a single nucleotide polymorphism of protein tyrosine phosphatase non-receptor type 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::436dc9ea4da9c9ae4143b3569e8557e2
http://hdl.handle.net/10807/161160
http://hdl.handle.net/10807/161160
Publikováno v:
Clinical Gastroenterology and Hepatology. 17:A26
Autor:
Edoardo G. Giannini, Vincenzo Savarino, Fabio Farinati, Francesca Ciccarese, Gianludovico Rapaccini, Mariella Di Marco, Luisa Benvegnu, Franco Borzio, Eugenio Caturelli, Maria Chiaramonte, The Italian Liver Cancer group [. . ., Virginia Erroi, Donatella Magalotti, Sabina Olmi, Emanuela Giampalma, Rita Golfieri, DOMENICALI, MARCO, ZOLI, MARCO, TREVISANI, FRANCO, BERNARDI, MAURO, BISELLI, MAURIZIO, CASSINI, ROMINA, CARACENI, PAOLO, CUCCHETTI, ALESSANDRO, GRAMENZI, ANNAGIULIA, RAVAIOLI, MATTEO, BALSAMO, CLAUDIA, MOSCONI, CRISTINA, RENZULLI, MATTEO, ROSELLI, PAMELA, RISSO, DAVIDE, BOSCO, GIOVANNA
Background: The role of clinically significant portal hypertension on the prognosis of cirrhotic patients undergoing hepatic resection for hepatocellular carcinoma (HCC) is debated. Aims: In this study, our aim was to assess the role of clinically si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07467fa2ca40b3d90aa9f87c7e2f3dc9
http://hdl.handle.net/11585/254695
http://hdl.handle.net/11585/254695
Autor:
F.G. Vaccaro, A. Liguori, Marco Biolato, Antonio Craxì, Antonio Grieco, C. Cefalo, Antonio Gasbarrini, Gianludovico Rapaccini, D. Arzani, Luca Miele, Salvatore Petta, R. Pastorino, Giuseppe Marrone, C. Araneo, Stefania Boccia, Valentina Giorgio
Publikováno v:
Digestive and Liver Disease. 49:e3